Research Topics
| M ReboljSummaryAffiliation: University of Copenhagen Country: Denmark Publications
| Collaborators
|
Detail Information
Publications
Incidence of cervical cancer after several negative smear results by age 50: prospective observational studyMatejka Rebolj
Erasmus MC, Department of Public Health, PO Box 2040, 3000 CA Rotterdam, Netherlands
BMJ 338:b1354. 2009..To determine the incidence of cervical cancer after several negative cervical smear tests at different ages...
False-positive Human Papillomavirus DNA tests in cervical screening: it is all in a definitionMatejka Rebolj
Department of Public Health, University of Copenhagen, Øster Farimagsgade 5, 1014 København K, Denmark
Eur J Cancer 47:255-61. 2011..The aim of this paper was to illustrate how the narrow definition affected the measured adverse effects of HPV DNA screening compared with cytology screening...- Incomplete follow-up of positive HPV tests: overview of randomised controlled trials on primary cervical screeningM Rebolj
Department of Public Health, University of Copenhagen, Øster Farimagsgade 5, DK 1014 København K, Denmark
Br J Cancer 103:310-4. 2010..We assessed the compliance and its impact on > or =CIN3 detection in all eight randomised controlled trials (RCT) with published baseline-round data... 
Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategiesMatejka Rebolj
Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
Int J Cancer 121:1529-35. 2007..Therefore, we advocate including HPV testing before referring to colposcopy. Among the 3 HPV strategies, analysis of additional aspects favors implementation of immediate HPV testing...- Primary HPV screening for cervical cancer prevention: results from European trialsElsebeth Lynge
Institute of Public Health, University of Copenhagen, Denmark
Nat Rev Clin Oncol 6:699-706. 2009.... - What women want. Women's preferences for the management of low-grade abnormal cervical screening tests: a systematic reviewM E Frederiksen
Department of Public Health, University of Copenhagen, Copenhagen, Denmark
BJOG 119:7-19. 2012..Several available alternatives for the follow-up of low-grade abnormal screening tests have similar outcomes. In this situation, women's preferences have been proposed as a guide for management decisions... - Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the NetherlandsMatejka Rebolj
Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
Int J Cancer 120:806-12. 2007..In conclusion, the 1996 changes in protocols and guidelines, and their implementation have increased coverage and efficiency, and decreased the screening-induced negative side effects... - The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screeningI M C M de Kok
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Br J Cancer 100:1240-4. 2009..The CERs of cancer screening programmes will clearly increase, with approximately 4000 euro. However, because of the favourable CER's, including unrelated healthcare costs will in general have limited policy implications... - No increased risk for cervical cancer after a broader definition of a negative Pap smearMatejka Rebolj
Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
Int J Cancer 123:2632-5. 2008.... - Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the NetherlandsAnita B Bos
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Int J Cancer 119:2372-5. 2006..We conclude that increasing screening participation has much more potential for further reducing cervical cancer incidence than reducing the screening interval, increasing the age range or having a screening test with higher sensitivity...